ReviewO&G open2024
Administration of the Postpartum Glucose Tolerance Test During the Delivery Hospitalization Compared With 4-12 Weeks Postpartum: A Systematic Review and Meta-Analysis.
Review in O&G open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial.Obstetrics and gynecology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the rate of noncompletion of testing for type 2 diabetes in individuals with gestational diabetes mellitus (GDM) with a fasting 75-g, 2-hour oral glucose tolerance test in the immediate postpartum period before hospital discharge compared with 4-12 weeks postpartum by performing a systematic review and meta-analysis. DATA SOURCES: We explored EMBASE, MEDLINE, Web of Science, CINAHL, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials for studies comparing the rate of type 2 diabetes screening in individuals with GDM in the immediate postpartum period before hospital discharge with 4-12 weeks postpartum. METHODS OF STUDY SELECTION: Two reviewers separately identified studies, obtained data, and gauged study quality. The rate of type 2 diabetes screening was compared, and odds ratios (ORs) with 95% CIs were estimated. TABULATION INTEGRATION AND
resultsFive prospective and two retrospective cohort studies were identified with 2,254 individuals with GDM at 13 hospitals. Studies evaluated individuals with GDM who delivered and underwent screening for type 2 diabetes in the immediate postpartum period from May 1994 through October 2021. Four studies were from the United States, and one was from Korea, Brazil, and Iran. In these studies, testing was offered in both periods: A pooled proportion of 6.6% (95% CI, 0.23-20.5%) did not complete immediate postpartum testing before hospital discharge, and 53.0% (95% CI, 37.1-68.6%) did not complete testing at 4-12 weeks postpartum. The overall rate of noncompletion of screening in the immediate postpartum period was lower compared with individuals who had screening in the 4-12 week follow-up (pooled OR 0.21, 95% CI, 0.05-0.79,
conclusionImproved compliance with screening for type 2 diabetes in individuals diagnosed with GDM can be achieved after delivery before hospital discharge compared with screening at 4-12 weeks postpartum. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42024530659.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.